← Eichor
Condition: Lipoprotein Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lipoprotein Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · 249 location(s) · Amgen · NCT07136012Differential Thrombogenesis by EPA and DHA Mediated by HDL
EARLY_Phase 1 · 1 location(s) · The Miriam Hospital · NCT06494488Mechanism of Ketogenic Diet-Induced Hypercholesterolemia
NA · 1 location(s) · Washington University School of Medicine · NCT06894004Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
NA · 1 location(s) · Université de Sherbrooke · NCT04227678A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
Phase 1 · 1 location(s) · CSL Behring · NCT07619820Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Ident
Phase N/A · 1 location(s) · E.S.stroes · NCT06995183An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · 635 location(s) · Novartis Pharmaceuticals · NCT07517263AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)
Phase N/A · 1 location(s) · University of Galway · NCT07577609Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Establish
Phase 3 · 95 location(s) · Novartis Pharmaceuticals · NCT06813911A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Particip
Phase 1 · 6 location(s) · AstraZeneca · NCT06980428Low-carbohydrate Diet and Low-Density Lipoprotein - Cholesterol (LDL-c) Interindividual Variability
NA · 1 location(s) · University of Bath · NCT07675603Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
Phase 3 · 40 location(s) · Amgen · NCT07293260Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · 772 location(s) · Eli Lilly and Company · NCT07157774Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.
NA · 2 location(s) · Odense University Hospital · NCT05614219Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a
NA · 1 location(s) · Duke University · NCT06471036A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Phase 1 · 2 location(s) · Monash University · NCT07428473Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-El
NA · 2 location(s) · Sin Gon Kim · NCT07359105Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT03512132Testing for Increased Lipoproteins (a) [LP(a)] in Lymphedema Patients: Li-LY
NA · 2 location(s) · Centre Hospitalier Universitaire de Nice · NCT05962827Causes and Natural History of Dyslipidemias
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00353782The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients W
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire Dijon · NCT07564752Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterole
Phase 3 · 19 location(s) · Novartis Pharmaceuticals · NCT06597006The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)
NA · 2 location(s) · Arkansas Children's Hospital Research Institute · NCT05992688Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition
NA · 1 location(s) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador · NCT07004777Atlantic Lipid Lowering Treatment Optimization Program
NA · 2 location(s) · Atlantic Health System · NCT06439654The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial Deformation
Phase N/A · 2 location(s) · University of Athens · NCT07324902Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Phase 3 · 84 location(s) · Immunovant Sciences GmbH · NCT07039916Relationship Between High-Density Lipoprotein Subtypes and Coronary Heart Disease Prognosis.
Phase N/A · 1 location(s) · Beijing Tsinghua Chang Gung Hospital · NCT06190834Assessment of Compliance With European and French Guidelines for the Management of Dyslipidaemias
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT03449784Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.